Control of apoptosis during angiogenesis by survivin expression in endothelial cells

American Journal of Pathology

Volumn 156, Issue 2, 2000, Pages 393-398

  O’connor, Daniel S ^a   Schechner, Jeffrey S ^a,b   Adida, Colette ^a   Mesri, Mehdi ^a   Rothermel, Annette L ^a   Li, Fengzhi ^a   Nath, Anjali K ^a   Pober, Jordan S ^a,b   Altieri, Dario C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CASPASE 3; CYCLOHEXIMIDE; MITOGENIC AGENT; RNA; SURVIVIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MITOGENESIS; PRIORITY JOURNAL; PROTEIN INDUCTION; SKIN CAPILLARY; TUMOR VASCULARIZATION;

EID: 0033870417     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64742-6     Document Type: Article

References (34)

1. Cell death in development
2. Caspases: Intracellular signaling by proteolysis
3. Apoptosis in the pathogenesis and treatment of disease
4. Apoptosis and disease: Regulation and clinical relevance of programmed cell death
5. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability
6. Apoptosis in the failing human heart
7. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart
8. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia
9. Modulation of endothelial cell apoptosis: Mechanisms and pathophysiological roles
10. Protective genes expressed in endothelial cells: A regulatory response to injury
11. Mechanisms of angiogenesis
12. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal
13. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
14. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody
15. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
16. Control of apoptosis and mitotic spindle checkpoint by survivin
17. cAMP and tumor necrosis factor competitively regulate transcriptional activation through and nuclear factor blinding to the cAMP-responsive element/activating transcription factor element of the endothelial leukocyte adhesion molecule-1 (E-selectin) promoter
18. Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line
19. Biological action of leptin as an angiogenic factor
20. Integrin αVβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
21. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells
22. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression
23. Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2- dependent and independent mechanisms
24. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting
25. IAP family proteins: Suppressors of apoptosis
26. The inhibitors of apoptosis (IAPs) and their emerging role in cancer
27. Control of adhesiondependent cell survival by focal adhesion kinase
28. Caspasemediated cleavage of focal adhesion kinase pp125(FAK) and disassembly of focal adhesions in human endothelial cell apoptosis
29. 1 mediates apoptosis in endothelial cell through activation of Cdk2: Role of a caspase cascade
30. The Bcl-2 protein family: Arbiters of cell survival
31. Death by design: Programmed cell death in cardiovascular biology and disease
32. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury
33. Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia
34. Angiogenesis: Mechanistic insights, neovascular diseases, and therapeutic prospects